TCRT
Price:
$3.59
Market Cap:
$8.01M
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and developm...[Read more]
Industry
Biotechnology
IPO Date
2005-08-24
Stock Exchange
NASDAQ
Ticker
TCRT
According to Alaunos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.07M. This represents a change of -99.54% compared to the average of 1.32B of the last 4 quarters.
The mean historical Enterprise Value of Alaunos Therapeutics, Inc. over the last ten years is 367.66M. The current 6.07M Enterprise Value has changed 65.21% with respect to the historical average. Over the past ten years (40 quarters), TCRT's Enterprise Value was at its highest in in the September 2025 quarter at 5.26B. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.97M.
Average
367.66M
Median
312.33M
Minimum
1.97M
Maximum
901.49M
Discovering the peaks and valleys of Alaunos Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 246.19%
Maximum Annual Enterprise Value = 901.49M
Minimum Annual Increase = -91.06%
Minimum Annual Enterprise Value = 1.97M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 1.97M | -81.97% |
| 2023 | 10.91M | -91.06% |
| 2022 | 121.96M | -35.04% |
| 2021 | 187.73M | -55.09% |
| 2020 | 418.03M | -41.56% |
| 2019 | 715.34M | 246.19% |
| 2018 | 206.63M | -58.34% |
| 2017 | 495.98M | -19.55% |
| 2016 | 616.54M | -31.61% |
| 2015 | 901.49M | 91.84% |
The current Enterprise Value of Alaunos Therapeutics, Inc. (TCRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
44.94M
5-year avg
148.12M
10-year avg
367.66M
Alaunos Therapeutics, Inc.’s Enterprise Value is greater than Radiopharm Theranostics Limited (-27525699.85), greater than Cyclerion Therapeutics, Inc. (1.11M), greater than Pasithea Therapeutics Corp. (-4114320103.00), greater than VYNE Therapeutics Inc. (-13109994.00), less than Quoin Pharmaceuticals, Ltd. (9.45M), less than Addex Therapeutics Ltd (6.17M), greater than Polyrizon Ltd. (-1616231.00), greater than AIM ImmunoTech Inc. (4.19M), less than XTL Biopharmaceuticals Ltd. (7.96M), less than Impact BioMedical Inc. (27.60M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -27525699.85 | $5.91M | |
| 1.11M | $5.67M | |
| -4114320103.00 | $8.63M | |
| -13109994.00 | $6.24M | |
| 9.45M | $11.12M | |
| 6.17M | $5.54M | |
| -1616231.00 | $14.21M | |
| 4.19M | $4.19M | |
| 7.96M | $4.76M | |
| 27.60M | $5.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alaunos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alaunos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Alaunos Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?
What is the 3-year average Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?
What is the 5-year average Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?
How does the current Enterprise Value for Alaunos Therapeutics, Inc. (TCRT) compare to its historical average?